Perfusion Index and Labor Analgesia

Erzincan University30 enrolled

Overview

It can be suggested that sympathetic tonus increase and pain, caused by the removal of the effect of epidural analgesia applied at birth, may also affect perfüsion index. The purpose of this study is; To correlate the VAS value at the time of return of epidural analgesia with the PI values at that time and, to test the possibility of using PI variants as an objective tool for predicting pain initiation time and assessing pain.

Study Type

OBSERVATIONAL

Enrollment

Conditions

perfüsion Index in Removal of the Epidural Analgesia

Interventions

perfüsion indexDIAGNOSTIC_TEST

Determination of the relationship between VAS values and PI in patients with normal delivery who undergo epidural analgesia

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * women who will give normal spontaneous vaginal delivery * Between the ages of 18-45 Exclusion Criteria: * Patients who do not accept the procedure, * those under 18 years of age - over 45 years, * those with low platelet counts, * those with infection at the puncture site, * those with progressive neurological disease, * Those with increased intracranial pressure, * those with hypovolemia

Locations (1)

Erzincan University

Erzincan, Turkey (Türkiye)

RECRUITING

Outcomes

Primary Outcomes

relationship between Visual analogue scale and Perfüsion index

Determination of the relationship between VAS values and PI in patients with normal delivery who undergo epidural analgesia,

Time frame: three month

Secondary Outcomes

relationship between heart rate and Perfüsion index

Determination of the relationship between heart rate and PI in patients with normal delivery who undergo epidural analgesia,

Time frame: three month

relationship between non-invazive blood pressure and Perfüsion index

Determination of the relationship between non-invazive blood pressure and PI in patients with normal delivery who undergo epidural analgesia,

Time frame: three month

Central Contacts

ilke kupeli

CONTACT

5555485632 ilkeser2004@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.